Spatial profile of tumors study
Part of Cancer clinical trials.
This study is looking at the unique 'spatial profile' of tumors to better understand how cancer cells are arranged and behave. It may help doctors learn more about your specific tumor type and guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a primary or metastatic tumor (cancer) that has been diagnosed by biopsy, imaging, or endoscopy.
- You must be willing to sign a consent form (or have someone sign for you if needed).
- You cannot have had a different type of cancer in the past that is unrelated to your current tumor.
- You cannot have a serious active infection (like HIV, hepatitis B or C, or other ongoing bacterial/viral infections).
- You cannot have an active autoimmune disease, and cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects tumor tissue and related blood tests from people who already need a biopsy or surgery as part of their usual care. Researchers use the samples to learn what drives the tumor and how the tumor environment may affect treatment, which could help develop future therapies.
This study looks at tumor tissue and/or blood “biomarkers” to help predict whether a solid tumor will respond well to radiation therapy. It may help doctors choose more effective treatments in the future, and it may guide your care during radiotherapy if you qualify.
This study helps doctors better understand your cancer by doing tumor/cancer profiling as part of research. If you qualify, your participation may help improve how cancers are studied and matched with future treatments.
This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.
This study looks at the genetic information (DNA) from your blood and from saved tumor tissue to better understand certain cancers, especially rare cancers with a poor outlook. It may help researchers learn why these cancers behave the way they do and guide future treatments.
This study helps researchers improve outcomes for solid tumors by setting up a way to collect tissue samples. If you’re receiving care at Barts Health NHS Trust and can consent, your samples may be used for research, even if you’re in another trial.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.